Literature DB >> 10433217

Regulation of glucose transporters by estradiol in the immature rat uterus.

R D Welch1, J Gorski.   

Abstract

A series of metabolic changes within the immature rat uterus begins minutes after the administration of microgram quantities of estradiol (E2). One of the earliest effects that has been measured is an increase in the rate at which the uterus takes up glucose. To characterize the effect of E2 on glucose transport stimulation, whole protein preparations were examined for the presence of mammalian glucose transport proteins Glut1 through Glut5. E2-stimulated changes in the steady state levels of messenger RNA (mRNA) and protein were measured for Glut1 and Glut4 by quantitative competitive RT-PCR and Western blots. Both Glut1 mRNA and protein increased approximately 3- to 4-fold within 4-8 h. This increase in Glut1 mRNA and protein agrees with the maximal stimulation of the glucose transport rate that was observed. No translocation of either Glut1 or Glut4 was observed 2 h after E2 injection, indicating that translocation is not the mechanism responsible for the initial E2-stimulated increase in glucose transport observed in immature rat uterus. These data support the conclusion that the prolonged increase in glucose transport rate is due to either the transcriptional activation of Glut1 and/or the increased Glut1 mRNA half-life.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433217     DOI: 10.1210/endo.140.8.6923

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.

Authors:  Xin Li; Peng Cui; Hong-Yuan Jiang; Yan-Rong Guo; Bano Pishdari; Min Hu; Yi Feng; Håkan Billig; Ruijin Shao
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

2.  A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.

Authors:  Ting Liu; Kavindra Nath; Weixia Liu; Rong Zhou; I-Wei Chen
Journal:  NMR Biomed       Date:  2015-07-14       Impact factor: 4.044

Review 3.  Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2011-10-09       Impact factor: 3.201

Review 4.  Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.

Authors:  Antonina I Frolova; Kelle H Moley
Journal:  Reproduction       Date:  2011-06-03       Impact factor: 3.906

5.  Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status.

Authors:  Julie Hanson Ostrander; Christine M McMahon; Siya Lem; Stacy R Millon; J Quincy Brown; Victoria L Seewaldt; Nimmi Ramanujam
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

Review 6.  Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.

Authors:  Maureen M B Schulte; Jui-he Tsai; Kelle H Moley
Journal:  Reprod Sci       Date:  2014-12-07       Impact factor: 3.060

Review 7.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

8.  Inhibition of oxygen-induced hypoxia-inducible factor-1alpha degradation unmasks estradiol induction of vascular endothelial growth factor expression in ECC-1 cancer cells in vitro.

Authors:  Kristin Happ Molitoris; Armina A Kazi; Robert D Koos
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Neonatal diethylstilbestrol exposure alters the metabolic profile of uterine epithelial cells.

Authors:  Yan Yin; Congxing Lin; G Michael Veith; Hong Chen; Maulik Dhandha; Liang Ma
Journal:  Dis Model Mech       Date:  2012-05-31       Impact factor: 5.758

Review 10.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.